By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina today reported preliminary first-quarter revenues of $270 million, down more than 4 percent compared to the first quarter of 2011 but above Wall Street's consensus estimate of $257.4 million.

The company, which plans to formally report first-quarter results later this month, added that it expects non-GAAP earnings per share for the first quarter to be "at or above current consensus estimates."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.